Original Articles
Visualizações

Arq. Bras. Oftalmol. 2021; 84 (3): 10.5935/0004-2749.20210040

Total: 2274

Fluorofenidone inhibits epithelial-mesenchymal transition in human lens epithelial cell line FHL 124: a promising therapeutic strategy against posterior capsular opacification

Hua Zhuang1,2; Ning-Xuan Zheng3; Lin Lin4; Wu-Zhen Zhang5; Wan-Yu Zhang6; Qin-Qi Yu7; Wei Xu8

DOI: 10.5935/0004-2749.20210040

1. Fuzhou Aier eye Hospital, Fuzhou, China
2. Fujian Medical University Union Hospital, Fu Zhou, Fujian Province, China
3. Fujian Center for Disease Control and Prevention, Fu Zhou, Fujian Province, China
4. Women and Children’s Hospital Affiliated to Xiamen University, Xiamen, Fujian Province, China
5. Xianyou maternal and Child Health Hospital, Putian, 351200, Fujian Province, China
6. Fujian Children’s Hospital, Fu Zhou, Fujian Province, China
7. Yongzhou First People’s Hospital, Hunan Province, China
8. The 1st affiliated hospital of Fujian Medical University, Fu Zhou, Fujian Province, China

Corresponding author

Wei Xu
Email: [email protected]

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.


Print PDF English
Open Access
Share

How to cite this article:

Zhuang1 H, 2 , Zheng N, Lin L, Zhang W, Zhang W, et al. Fluorofenidona inibe a transição epitélio-mesenquimal na linha celular FHL 124 do cristalino humano: uma promissora estratégia terapêutica contra a opacificação capsular posterior. Arq. Bras. Oftalmol. 2021;84(3):. 10.5935/0004-2749.20210040
Export citation